Hisamitsu Pharmaceutical Co., Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3784600003
JPY
6,400.00
6357.95 (15119.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Nov'25
Aug'25
May'25
Feb'25
Nov'24
Aug'24
May'24
Net Sales
39,571.00
40,278.00
34,665.00
44,753.00
35,797.00
39,646.00
35,810.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
39,571.00
40,278.00
34,665.00
44,753.00
35,797.00
39,646.00
35,810.00
Raw Material Cost
16,428.00
15,472.00
13,379.00
19,945.00
13,818.00
16,042.00
15,005.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.00
8.00
2.00
8.00
0.00
12.00
4.00
Selling and Distribution Expenses
18,662.00
20,043.00
17,920.00
19,133.00
17,765.00
15,995.00
14,301.00
Other Expenses
-0.50
-0.80
-0.20
-0.80
0.00
274.00
235.00
Total Expenditure (Excl Depreciation)
35,090.00
35,515.00
31,299.00
39,078.00
31,583.00
34,789.00
31,660.00
Operating Profit (PBDIT) excl Other Income
4481
4763
3366
5675
4214
4857
4150
Other Income
2,052.00
1,674.00
429.00
3,952.00
2,092.00
1,343.00
2,770.00
Operating Profit (PBDIT)
8,273.00
8,244.00
5,485.00
11,457.00
7,822.00
7,776.00
8,333.00
Interest
5.00
8.00
2.00
8.00
0.00
12.00
4.00
Exceptional Items
-196.00
-185.00
0.00
-343.00
0.00
0.00
0.00
Gross Profit (PBDT)
23,143.00
24,806.00
21,286.00
24,808.00
21,979.00
23,604.00
20,805.00
Depreciation
1,740.00
1,807.00
1,690.00
1,830.00
1,516.00
1,576.00
1,413.00
Profit Before Tax
6,334.00
6,243.00
3,791.00
9,275.00
6,311.00
6,186.00
6,915.00
Tax
1,345.00
1,652.00
1,154.00
1,035.00
1,650.00
1,756.00
1,944.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
4,869.00
4,458.00
2,564.00
8,098.00
4,562.00
4,309.00
4,789.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
4,869.00
4,458.00
2,564.00
8,098.00
4,562.00
4,309.00
4,789.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
121.00
132.00
73.00
142.00
98.00
121.00
182.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4,990.00
4,590.00
2,637.00
8,240.00
4,660.00
4,430.00
4,971.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,68,893.00
2,65,937.00
2,70,376.00
2,76,826.00
2,59,891.00
2,73,575.00
2,64,580.00
Earnings per share (EPS)
68.69
61.78
35.1
110.39
62.21
58.74
63.81
Diluted Earnings per share
68.69
61.78
35.1
110.39
62.21
58.74
63.81
Operating Profit Margin (Excl OI)
11.32%
11.83%
9.71%
12.68%
11.77%
12.25%
11.59%
Gross Profit Margin
20.4%
19.99%
15.81%
24.81%
21.86%
19.58%
23.26%
PAT Margin
12.3%
11.07%
7.4%
18.09%
12.74%
10.87%
13.37%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Nov 2025 is 10.54% vs -0.15% in Nov 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Nov 2025 is 7.08% vs 22.34% in Nov 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Nov 2025 is 8.57% vs 13.69% in Nov 2024

stock-summary

Interest

YoY Growth in quarter ended Nov 2025 is 0.00% vs -100.00% in Nov 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Nov 2025 has fallen from Nov 2024

Compare Quarterly Results Of Hisamitsu Pharmaceutical Co., Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
39,571.00
68,737.00
-29,166.00
-42.43%
Other Operating Income
0.00
0.00
0.00
Total Operating income
39,571.00
68,737.00
-29,166.00
-42.43%
Raw Material Cost
16,428.00
33,795.00
-17,367.00
-51.39%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.00
749.00
-744.00
-99.33%
Selling and Distribution Expenses
18,662.00
21,204.00
-2,542.00
-11.99%
Other Expenses
-0.50
545.80
-546.30
-100.09%
Total Expenditure (Excl Depreciation)
35,090.00
61,206.00
-26,116.00
-42.67%
Operating Profit (PBDIT) excl Other Income
4,481.00
7,531.00
-3,050.00
-40.50%
Other Income
2,052.00
669.00
1,383.00
206.73%
Operating Profit (PBDIT)
8,273.00
12,697.00
-4,424.00
-34.84%
Interest
5.00
749.00
-744.00
-99.33%
Exceptional Items
-196.00
0.00
-196.00
Gross Profit (PBDT)
23,143.00
34,942.00
-11,799.00
-33.77%
Depreciation
1,740.00
4,497.00
-2,757.00
-61.31%
Profit Before Tax
6,334.00
7,450.00
-1,116.00
-14.98%
Tax
1,345.00
1,587.00
-242.00
-15.25%
Provisions and contingencies
0
0
0.00
Profit After Tax
4,869.00
5,878.00
-1,009.00
-17.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
4,869.00
5,878.00
-1,009.00
-17.17%
Share in Profit of Associates
0
0
0.00
Minority Interest
121.00
-15.00
136.00
906.67%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4,990.00
5,863.00
-873.00
-14.89%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,68,893.00
2,81,265.00
-12,372.00
-4.40%
Earnings per share (EPS)
68.69
17.28
51.41
297.51%
Diluted Earnings per share
68.69
17.28
51.41
297.51%
Operating Profit Margin (Excl OI)
11.32%
10.96%
0.00
0.36%
Gross Profit Margin
20.40%
17.38%
0.00
3.02%
PAT Margin
12.30%
8.55%
0.00
3.75%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3,957.10 Million
in Nov 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Nov 2025 is -1.76% vs 16.19% in Aug 2025

stock-summary

YoY Growth in quarter ended Nov 2025 is 10.54% vs -0.15% in Nov 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 499.00 Million
in Nov 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Nov 2025 is 8.71% vs 74.06% in Aug 2025

stock-summary

YoY Growth in quarter ended Nov 2025 is 7.08% vs 22.34% in Nov 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 622.10 Million
in Nov 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Nov 2025 is -5.31% vs 29.94% in Aug 2025

stock-summary

YoY Growth in quarter ended Nov 2025 is 8.57% vs 13.69% in Nov 2024

Quarterly - Interest
Interest 0.50 Million
in Nov 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Nov 2025 is -37.50% vs 300.00% in Aug 2025

stock-summary

YoY Growth in quarter ended Nov 2025 is 0.00% vs -100.00% in Nov 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.32%
in Nov 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Nov 2025 has fallen from Aug 2025

stock-summary

YoY Growth in quarter ended Nov 2025 has fallen from Nov 2024